Trial Profile
A Multicenter Trial Evaluating the Efficacy of Cesamet for the Symptomatic Treatment of Pain in Patients With Diabetic Peripheral Neuropathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2008
Price :
$35
*
At a glance
- Drugs Nabilone (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 14 Feb 2008 Status change from in progress to completed, as reported by clinicaltrials.gov.
- 27 Aug 2007 The expected completion date for this trial is now 1 Oct 2007.
- 13 Aug 2007 Status change from recruiting to in progress.